Document is current
Any future updates will be listed below
-
Authors
Meixensberger, Sophie
Bechter, Karl
Dersch, Rick
Feige, Bernd
Maier, Simon
Schiele, Miriam A.
Runge, Kimon
Denzel, Dominik
Nickel, Kathrin
Spieler, Derek
Urbach, Horst
Prüss, Harald
Domschke, Katharina
Tebartz van Elst, Ludger
Endres, Dominique https://orcid.org/0000-0001-7322-1195
-
Funding
Funding for this research was provided by:
The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science, Research and Art and the University of Freiburg in the funding programme Open Access Publishing.
Projekt DEAL
- License Information
-
More Information
Article History
Received: 1 August 2020
Accepted: 6 October 2020
First Online: 11 November 2020
Ethics approval and consent to participate
: This retrospective analysis received approval from the local ethics committee of the University of Freiburg (EK Fr 396/18). The patients gave their written informed consent before the lumbar puncture.
: Not applicable.
: SMe: None. KB: None. RD: Lecture fees from Roche and travel grants from Biogen. BF: None. SMa: None. MAS: None. KR: None. DD: None. KN: None. DS: None. HU: Shareholder of the Veobrain: HP: None. KD: Steering Committee Neurosciences, Janssen. LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics. DE: None.
